Nova Patents
IS5079A

Ziprasidone formulations

Abstract

Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.

Term

Term ended

Projected expiry passed 11 June 2019, 7.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

78 members in 46 offices

This recordMember, by publication datePriority claim36 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
8922998United States of AmericaP
8922998United States of AmericaP
US19980089229P–––

Members78

Family members, oldest first
DocumentOfficeKind
NO992892D0NorwayD0
AP9901579A0African Regional Intellectual Property Organization (ARIPO)A0
HU9901960D0HungaryD0
HN1999000089AHondurasA
CA2274338A1CanadaA1
IS5079AThis recordIcelandA
NO992892LNorwayL
PL333737A1PolandA1
EP0965343A2European Patent Office (EPO)A2
AU3398399AAustraliaA
EA199900467A2Eurasian Patent Organization (EAPO)A2
JP2000007566AJapanA
TR1999001379A2TürkiyeA2
TR199901379A2TürkiyeA2
KR20000006143ARepublic of KoreaA
CN1242987AChinaA
EP0965343A3European Patent Office (EPO)A3
UY25649A1UruguayA1
HRP990193A2CroatiaA2
EA199900467A3Eurasian Patent Organization (EAPO)A3
BR9902268ABrazilA
ID23546AIndonesiaA
IL130424A0IsraelA0
IL130424D0IsraelD0
PE20000632A1PeruA1
BG103489ABulgariaA
HU9901960A2HungaryA2
HUP9901960A2HungaryA2
CZ212799A3CzechiaA3
HU9901960A3HungaryA3
HUP9901960A3HungaryA3
PA8475601A1PanamaA1
HK1024184AHong Kong, ChinaA
HK1024184A1Hong Kong, ChinaA1
NZ336271ANew ZealandA
US6150366AUnited States of AmericaA
GT199900080AGuatemalaA
SK76999A3SlovakiaA3
ZA993938BSouth AfricaB
SG77243A1SingaporeA1
AR015553A1ArgentinaA1
CO5070579A1ColombiaA1
JP2002003492AJapanA
EA002223B1Eurasian Patent Organization (EAPO)B1
OA11064AAfrican Intellectual Property Organization (OAPI)A
KR100338915B1Republic of KoreaB1
AU753820B2AustraliaB2
YU27199AYugoslavia, later Serbia and Montenegro (until 2006)A
CA2274338CCanadaC
EP0965343B1European Patent Office (EPO)B1
AT240732TAustriaT
ATE240732T1AustriaT1
DE69908021D1GermanyD1
DK0965343T3DenmarkT3
PT965343EPortugalE
HRP990193B1CroatiaB1
JP3441676B2JapanB2
UA59383C2UkraineC2
AP1216AAfrican Regional Intellectual Property Organization (ARIPO)A
IL130424AIsraelA
SI0965343T1SloveniaT1
DE69908021T2GermanyT2
ES2197581T3SpainT3
NO316713B1NorwayB1
TW590774BTaiwan Province of ChinaB
MA26647A1MoroccoA1
BG64691B1BulgariaB1
MY121397AMalaysiaA
IS2182BIcelandB
CN1307994CChinaC
CZ297954B6CzechiaB6
RS49611BSerbiaB
PL195209B1PolandB1
PL195606B1PolandB1
SK286245B6SlovakiaB6
JP4187423B2JapanB2
HU226487B1HungaryB1
CY2003002I1CyprusI1